Cardiovascular

Therapeutic MK2i-NP blocks both inflammation and an unhealthy conversion of cells in blood vessels after cardiovascular procedures, reducing the need for further interventions—cutting costs and reducing risks. Est. reading time: 2.5 minutes. Read More

Vanderbilt University Medical Center (VUMC) has been named one of the nation’s top 50 hospitals in cardiovascular services by Truven Health Analytics. Read More

If you’re looking for a simple way to lower your risk of dying from a heart attack, consider going nuts. Read More

A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression. Read More

When it comes to taking care of our hearts, there is a big divide between what we should do and what we actually do, a new multi-institution study reports. Read More

HDL cholesterol is impaired in patients with chronic kidney disease – and may increase their cardiovascular disease risk. Read More

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles. Read More

The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure. Read More

Levels of the protein NGAL may be a good predictor of worsening kidney function in patients with acute heart failure. Read More

A genetic variant may help keep an individual’s “good” cholesterol in check. Read More

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure. Read More

A certain signaling pathway could be key to improving cardiac repair after a heart attack. Read More